WHO Consultation: Preferred product characteristics for monoclonal antibodies for malaria prevention
The WHO Global Malaria Programme (GMP) is seeking public comment on preferred product characteristics (PPCs) for monoclonal antibodies for malaria prevention. PPCs are becoming a key tool for WHO to incentivize and guide the development of urgently needed health products. Consultation deadline August 12, 2022.